Arrowhead Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.5% | -34.5% | -19.8% |
| FY2022 | -44.2% | -44.2% | -25.4% |
| FY2023 | -75.7% | -75.7% | -26.8% |
| FY2024 | -323.3% | -323.3% | -52.6% |
| FY2025 | -0.3% | -0.3% | -0.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.5% | -34.5% | -19.8% |
| FY2022 | -44.2% | -44.2% | -25.4% |
| FY2023 | -75.7% | -75.7% | -26.8% |
| FY2024 | -323.3% | -323.3% | -52.6% |
| FY2025 | -0.3% | -0.3% | -0.1% |